Valuation check: SLGL's profit margin is -910.14%, below the Healthcare sector average of 21.34%.
Get informed when a big investor buys or sells
+ FollowAs of Jun 2026
Trailing 12 months ending Jun 2026
As of the most recent data (June 2026), SLGL shows a profit margin of -910.14%. That compares with -14.25% in the prior-year period — down 6287.3% year over year. That is below the Healthcare sector average of 21.34%. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, SLGL's profit margin is now -910.14% (was -14.25%) — a 6287.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sol-Gel Technologies is outperforming or lagging.
The Healthcare sector average profit margin is about 21.34%. Sol-Gel Technologies is at -910.14%, which is lower that average. That is roughly 4365.9% below the sector mean. Use the comparison chart on this page to see how SLGL stacks up against individual peers as well.
That compares with -14.25% in the prior-year period — down 6287.3% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Sol-Gel Technologies with peers to see if the move is company-specific or sector-wide.
Besides this profit margin page, Stockcircle has Sol-Gel Technologies's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently -910.14%) with ownership activity and broader fundamentals.